Bill Text: US HR1125 | 2019-2020 | 116th Congress | Introduced
Bill Title: Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
Spectrum: Partisan Bill (Democrat 23-0)
Status: (Introduced - Dead) 2020-09-18 - Referred to the House Committee on Energy and Commerce. [HR1125 Detail]
Download: US_Congress-2019-HR1125-Introduced.pdf